Polls
Experts Warn GLP-1 Drugs Carry Hidden Bone Risks for Older Adults
GLP-1 medications like Ozempic boost fracture risks by 11% in older type 2 diabetes patients, new research warns.
Experts demand bone density screenings before use to counter rapid weight loss effects on skeletal strength.
“Both older age and type 2 diabetes are independent risk factors for fragility fractures,” said study lead author Dr. Michal Kasher Meron.
“Bone health should be assessed before starting these medications in older patients — not as an afterthought.”
Liberty Check
- Journal of Clinical Endocrinology & Metabolism study of 46,000+ seniors shows statistically significant fracture increase versus other diabetes drugs.
- Separate analysis links GLP-1s to 29% higher osteoporosis risk, elevated gout (7.4% vs. 6.6%), and doubled osteomalacia incidence.
- Mechanisms include reduced mechanical bone loading and nutrient deficits; counter with nutrition, resistance training, and vigilance against Big Pharma overreach.
Constitutional conservatives must prioritize informed consent and limited government interference in personal health choices amid these revelations.
Our freedoms depend on staying vigilant.
